論文（英文）

Takeuchi Y, Fujino Y, Fukushima K, Watanabe M, Nakagawa T, Ohno K, Sasaki N, Sugano S, Tsujimoto H. Biological effect of tyrosine kinase inhibitors on three canine mast cell tumor cell lines with various KIT statuses. J Vet Pharmacol Ther. 2012; 35(1): 97–104.
Takeuchi Y, Fujino Y, Watanabe M, Nakagawa T, Ohno K, Sasaki N, Sugano S, Tsujimoto H. Screening of therapeutic targets for canine mast cell tumors from a variety of kinase molecules. J Vet Med Sci. 2011; 73(10): 1295–1302.
Shinohara N, Abe T, Mochizuki T, Kashiwagi A, Kanagawa K, Maruyama S, Sazawa A, Oba K, Nonomura K. Is Memorial Sloan-Kettering Cancer Center risk classification appropriate for Japanese patients with metastatic renal cell carcinoma in the cytokine era? Urol Oncol 2011; 31: 1276-82.
Ogihara T, Nakao K, Ueshima K, Oba K, Yasuno S, Fujimoto A, Matsuoka H, Saruta T, on behalf of the CASE-J Ex Study Group. Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex). Hypertens Res 2011;34:1295-301.
Mishima H, Oba K, Sakamoto J, Muro K, Yoshino T, Hyodo I, Maehara Y. Bevacizumab-containing therapy (5 mg/kg or 10 mg/kg) and FOLFIRI in advanced colorectal cancer failed to bevacizumab plus oxaliplatin-based therapy: A Phase III Study (EAGLE Study). Jpn J Clin Oncol 2011;42(2):134-8.
Ueshima K, Oba K, Yasuno S, Fujimoto A, Tanaka S, Ogihara T, Saruta T, Nakao K. Influence of coronary risk factors on coronary events in Japanese high-risk hypertensive patients: primary and secondary prevention of ischemic heart disease in a subanalysis of the CASE-J (Candesartan Antihypertensive Survival Evaluation in Japan) trial. Circ J 2011; 75: 2411-6.
Nishimura R, Nakamura S, Oba K, Komoike Y, Mitsuyama S, Hisamatsu K, Oriuchi N, Abe C, Kuwayama T, Taguchi T, Sakamoto J, Noguchi S. Prospective study on the effect of toremifene in patients with adjuvant anastrozole failure in postmenopausal breast cancer. Ann Cancer Res Ther 2011; 1: 9-14.
Hara T, Nishikawa K, Sakatoku M, Oba K, Sakamoto J, Omura K. Phase II study of weekly paclitaxel, cisplatin and 5-fluorouracil for advanced gastric cancer. Gastric Cancer 2011; 14: 332-8.
Okuyama Y, Hazama S, Nozawa H, Kobayashi M, Takahashi K, Fujikawa K, Kato T, Nagata N, Kimura H, Oba K, Sakamoto J, Mishima H. Prospective Phase II Study of FOLFIRI for mCRC in Japan, Including the Analysis of UGT1A1*28/*6 Polymorphisms. Jpn J Clin Oncol 2011;41: 477-82.
Oba K, Sato T, Ogihara T, Saruta T, Nakao K. How to use marginal structural models in randomized trials to estimate the natural direct and indirect effects of therapies mediated by causal intermediates. Clin Trials 2011; 8: 277-87.
Imamoto H, Oba K, Sakamoto J, Iishi H, Narahara H, Yumiba T, Morimoto T, Nakamura M, Oriuchi N, Kakutani C, Morita S, Shiozaki H. Assessing Clinical Benefit Response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer. Gastric Cancer 2011; 14: 81-90.
Oba K, Matsuoka M, Satoh T, Muro K, Oriuchi N, Sakamoto J, Mishima H. Multicentre Phase II Study of XELOX with Bevacizumab in Late-stage Elderly Patients with Unresectable Advanced/Recurrent Colorectal Cancer: An ASCA Study. Jpn J Clin Oncol 2011; 41: 134-8.
Isayama H, Yasuda I, Ryozawa S, Maguchi H, Igarashi Y, Matsuyama Y, Katanuma A, Hasebe O, Irisawa A, Itoi T, Mukai H, Arisaka Y, Okushima K, Uno K, Kida M, Tamada K. Results of a Japanese multicenter, randomized trial of endoscopic stenting for non-resectable pancreatic head cancer (JM-TEST): Covered wallstent versus doublelayer stent. Digestive Endoscopy 2011; 23(4): 310-315.
Higashi T, Hasegawa K, Kokudo N, Makuuchi M, Izumi N, Ichida T, Kudo M, Ku Y, Sakamoto M, Nakashima O, Matsui O, Matsuyama Y, Sobue T; the Liver Cancer Study Group of Japan. Demonstration of quality of care measurement using the Japanese liver cancer registry. Hepatology Research 2011; 41(12): 1208-1215.
Aoki T, Imamura H, Matsuyama Y, Kishi Y, Kobayashi T, Sugawara Y, Makuuchi M and Kokudo N. Convergence process of volumetric liver regeneration after living-donor hepatectomy. Journal of Gastrointestinal Surgery 2011; 15:1594-1601.
Eguchi S, Kanematsu T, Arii S, Omata M, Kudo M, Sakamoto M, Takayasu K, Makuuchi M, Matsuyama Y, Monden M; for the Liver Cancer Study Group of Japan. Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma. British Journal of Surgery 2011; 98(4): 552-557.
Araki Y, Matsuyama Y, Kobayashi Y, Toyokawa S, Inoue K, Suzuki S and Makimoto A. Secondary neoplasms after retinoblastoma treatment: Retrospective cohort study of 754 patients in Japan. Japanese Journal of Clinical Oncology 2011; 41(3): 373-379.

TOP